Preincubation of human resting T cell clones with interleukin 10 strongly enhances their ability to produce cytokines after stimulation

Cytokine

Volumn 10, Issue 11, 1998, Pages 831-840

  Lelievre, Eric ^a   Sarrouilhe, Denis ^a   Morel, Franck ^a   Preud'Homme, Jean Louis ^a   Wijdenes, John ^b   Lecron, Jean Claude ^a  

^a IBMIG Institut de Biologie Moleculaire et dIngenierie Genetique   (France)

^b Diaclone   (France)

Author keywords

Apoptosis; Cytokines; IL 10; T lymphocytes

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0032436159     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1998.0371     Document Type: Article

References (47)

1. + T cell clones and peripheral blood cells. J Immunol 149:2378-2384.
2. 2. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukin-10. Annu Rev Immunol 11:165-190.
3. 3. Hsu DH, De Waal Malefyt R, Fiorentino DF, Dang MN, Vieira P, De Vries JE, Spits H, Mosmann TR, Moore KW (1990) Expression of interleukin 10 activity by Epstein-Barr virus protein BCRF1. Science 250:830-831.
4. 4. Fiorentino DF, Bond MW, Mosmann TR (1989) Two types of mouse helper cell. VI. Th1 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 170:2081-2095.
5. 5. Vieira P, De Waal-Malefyt R, Dang MN, Johnson KE, Fiorentino DF, Dr Vries JE, Roncarolo MG, Mosmann TR, Moore KW (1991) Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr openreading frame BCRF1. Proc Natl Acad Sci USA 88:1172-1176.
6. 6. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822.
7. 7. De Waal-Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220.
8. 8. D'Andrea A, Aste-Amezago M, Valiante NM, Ma X, Kubin M, Trinchieri G (1993) Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 178:1041-1048.
9. 9. Arock M, Zuany-Amorim C, Singer M, Benhamou M, Pretolani M (1996) Interleukin-10 inhibits cytokine generation from mast cells. Eur J Immunol 26:166-170.
10. 10. De Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, De Vries JE (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174:915-924.
11. + T cell clones and resting T cells. J Immunol 150:4754-4763.
12. 12. Taga K, Tosato G (1992) IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 148:1143-1148.
13. 13. Vwiner HL (1997) Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 18:335-343.
14. 14. MacNeil IA, Suda T, Moore KW, Mosmann T, Zlotnik A (1990). IL-10, a novel growth cofactor for mature and immature T cells. J Immunol 145:4167.
15. 15. Thompson-Snipes L, Dhar V, Bond MW, Mosmann TR, Moore KW, Rennick DM (1991) Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med 173:507-510.
16. 16. Te Velde AA, De Waal Malefyt R, Huijbens RJF, De Vris JE, Figdor CG (1992) IL-10 stimulates monocytes FcγR surface expression and cytotoxic activity. J Immunol 149:4048-4052.
17. 17. Fluckiger AC, Garrone P, Durand I, Galizzi JP, Banchereau J (1993) IL-10 upregulates fonctional high affinity IL-2 receptors on normal and leukemic B lymphocytes. J Exp Med 178:1473-1481.
18. 18. Cohen SB, Katsikis PD, Feldmann M, Londei M (1994) IL-10 enhances expression of the IL-2 receptor alpha chain on T cells. Immunology 83:329-332.
19. 19. Itoh K, Hirohata S (1995) The role of IL-10 in human B cell activation, proliferation and differentiation. J Immunol 154:4341-4350.
20. 20. Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89:1890-1893.
21. 21. Defrance T, Vanbervlier B, Briere F, Durand I, Rousset F, Banchereau J (1992) Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J Exp Med 175:671-682.
22. 22. Arpin C, Déchanet J, Van Kooten C, Merville P, Grouard G, Brière F, Banchereau J, Liu Y (1995) Generation of memory B cells and plasma cells in vitro. Science 268:720-722.
23. 23. Levy Y, Brouet JC (1994) Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein. J Clin Invest 93:424-428.
24. 24. Taga K, Cherney B, Tosato G (1993) IL-10 inhibits apoptotic cell death in human T cells starved of IL-2. International Immunology 5:1599-1608.
25. 25. Taga K, Chretien J, Cherney B, Diaz L, Brown M, Tosato G (1994) Interleukin-10 inhibits apoptotic cell death in infectious monocucleosis T cells. J Clin Inves 94:251-260.
26. 26. Arai T, Hiromatsu K, Nishimura H, Kimura Y, Kobayashi N, Ishida H, Nimura Y, Yoshikai Y (1995) Endogenous interleukin 10 prevents apoptosis in macrophages during Salmonella infection. Biochem Biophys Res Commun 213:600-607.
27. + hematopoietic progenitor cells. Blood 88:2549-2558.
28. 28. Fluckiger AC, Durand I, Banchereau J (1994) Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 179:91-99.
29. 29. Ludewig B, Graf D, Gelderblom HS, Kroczek RA, Pauli G (1995) Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur J Immunol 25:1943-1950.
30. 30. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ (1995) Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995, 377:348-351.
31. + T cells. J Exp Med 184:19-29.
32. s) gene expression. Eur J Immunol 26:294-299.
33. 33. Kaneko S, Suzuki N, Koizumi H, Yamamoto S, Sakane T (1997) Rescue by cytokines of apoptotic cell death induced by IL-2 deprivation of human antigen-specific T cell clones. Clin Exp Immunol 109:185-193.
34. 34. Vella A, Teague TK, Ihle J, Kappler J, Marrack P, (1997) Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J Exp Med 186:325-330.
35. 35. Gombert W, Borthwick NJ, Wallace DL, Hyde H, Bofill M, Pilling D, Beverley PCL, Janossy G, Salmon M, Akbar AN (1996) Fibroblasts prevent apoptosis of IL-2-deprived T cells without inducing proliferation: a selective effect on Bcl-x expression, Immunomolgy 89:397-404.
36. 36. Cohen SBA, Crawley JB, Kahan MC, Feldmann M, Foxwell BMJ (1997) Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2. Immunology 92:1-5.
37. 37. Ayroldi E, Migliorati G, Cannarile L, Moraca R, Delfino DV, Riccardi C (1997) CD2 rescues T cells from T-cell receptor/CD3 apoptosis: a role for the Fas/Fas-L system. Blood 89:3717-3726.
38. 38. De Vries JE (1995) Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med 27:537-541.
39. 39. Fuchs AC, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, Kennedy JS, Rabson AR, Radwanski E, Affrime MB, Cutler DL, Grint PC, and Dinarello CA (1996) Clinical, hématologie, and immunologie effects of interleukin-10 in humans. J Clin Immunol 16:291-303.
40. 40. Llorente L, Zou W, Levy Y, Richaud-Patin Y, Widjenes J, Alcocer-Varela J, Alarcon-Segovia D, Galanaud P, Emilie D (1995) Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med 181:839-844.
41. 41. Giovarelli M, Musiani P, Modesti A, Dellabona P, Cassorati G, Allione A, Consalvo M, Cavallo F, di Pierro F, De Giovanni C, Musso T, Forni G (1995) Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory. J Immunol 155:3112-3123.
42. 42. Balasa B, Sarvetnick N (1996) The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. J Autoimmunity 9:283-286.
43. 43. Roncarolo MG, Yssel H, Touraine JL, Bacchetta R, Gebuhrer L, de Vries JE, Spits H (1988) Antigen recognition by MHC-incompatible cells of a human mismatched chimera. J Exp Med 168:2139-2152.
44. 44. Spits H, Yssel H, Terhorst C, de Vries JE (1982) Establishment of human T lymphocyte clones highly cytotoxic for an EBV-transformed B cell line in serum-free medium: isolation of clones that differ in phenotype and specificity. J Immunol 128:95-99.
45. 45. Yssel H, de Vries JE, Koken M, Van Blitterswiijk W, Spits H (1984) Serum-free medium for the generation and the propagation of human cytotoxic and helper T-cells clones. J Immunol Methods 74:219-227.
46. + T lymphocytes stimulated by the lectin jacalin. Eur J Immunol 25:2010-2018.
47. 47. Broome HE, Dargan CM, Krajewski S, Reed JC (1995) Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal. J Immunol 155:2311-2317.